home / stock / tlt:cc / tlt:cc news

TLT:CC News and Press, Theralase Technologies Inc.

Stock Information
Company Name: Theralase Technologies Inc.
Stock Symbol: TLT:CC
Market: TSXVC
Website: theralase.com
Menu
Get TLT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
TLT:CC - Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus

Toronto, Ontario--(Newsfile Corp. - June 30, 2026) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the saf...
TLT:CC - Theralase(R) Lists Warrants on the TSXV

Toronto, Ontario--(Newsfile Corp. - June 3, 2026) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe...

TLT:CC - Theralase Technologies Inc. reports Q1 results

2026-05-29 17:12:31 ET More on Theralase Technologies Inc. Theralase Technologies Inc. (TLT:CA) Q4 2025 Earnings Call Transcript Historical earnings data for Theralase Technologies Inc. Financial information for Theralase Technologies Inc. Read the full art...

TLT:CC - Theralase(R) Releases Q1 2026 Financial Statements

Theralase(R) Provides an Update on its Phase II Bladder Cancer Clinical Study Toronto, Ontario--(Newsfile Corp. - May 29, 2026) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated t...
TLT:CC - Theralase(R) Closes C$4.8 Million Offering

Toronto, Ontario--(Newsfile Corp. - May 20, 2026) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe...

TLT:CC - Theralase Technologies Inc. (TLT:CA) Q4 2025 Earnings Call Transcript

2026-05-12 14:50:52 ET Theralase Technologies Inc. (TLT:CA) Q4 2025 Earnings Call May 12, 2026 11:00 AM EDT... Read the full article on Seeking Alpha For further details see: Theralase Technologies Inc. (TLT:CA) Q4 2025 Earnings Call Transcript

TLT:CC - Theralase(R) Announces $4 Million Brokered LIFE Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical...
TLT:CC - Theralase Technologies Inc. reports FY results

2026-05-04 17:37:21 ET More on Theralase Technologies Inc. Historical earnings data for Theralase Technologies Inc. Financial information for Theralase Technologies Inc. Read the full article on Seeking Alpha For further details see: Theralase Technologie...

TLT:CC - Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update

Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe ...

TLT:CC - Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study

Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe...
Next 10